DR. NATHANIEL ADAMS

MDReal-Time Hydrated
Practice Location: HAZELWOOD, MO 63042
NPI Number: 1548838535
LIFETIME INDUSTRY VALUE
$168
2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ADAMS is a verified Internal Medicine practitioner based in HAZELWOOD, MO.

Between 2021 and 2024, Dr. ADAMS had an overall industry promotional and research financial footprint of $168 as recorded in the federal CMS Open Payments database.

  • $168 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
  • $0 was allocated to sponsored clinical trials and medical research activities.

Dr. ADAMS's primary funding source is SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, which accounts for $29 (representing 17.1% of overall industry footprint).

Data coverage: 2021 – 2024  ·  Source: CMS Open Payments  ·  CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments
Research Funding
$128$64$0$02021$02022$392023$1282024

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US
Rank 1
$29
17.1%
LILLY USA
Rank 2
$27
16.1%
NOVO NORDISK
Rank 3
$20
12.1%

General payments include consulting honoraria, promotional speaking fees, meals, travel, educational materials, and entertainment offsets.

PROMOTIONAL COUNT
Active
ESTIMATED COMPLIANCE RISK
Standard

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:
2024
2024
2023
2022
2021
Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.